The project‘s objectives are: a) to strengthen Drug Regulatory Authorities’ (DRA) capacities to handle new therapeutic life science innovations through the best practice area of clinical trials, and b) to be a forum for APEC members to discuss and share experiences in controls of clinical trials towards the harmonization of regulatory practices. This document zooms in on the area of drug development in clinical trials.

• Part I. General Information
• Part II. Presentations
• a) Presentations by Member Economies
• b) Presentations by Other Country Participants
• c) Presentations
• Part III. Summary of Round Table Discussion
• Part IV. List of Participants
• Part V. Questionnaires Survey Results